James Goldenring

June 17, 2025

Drug shows safety, efficacy for precancerous stomach lesions

The drug also showed promise that it could be the first therapeutic intervention against precancerous lesions in the stomach.

April 4, 2025

Study details genetic architecture of congenital diarrheal disorders in infants

The findings represent a significant advance toward development of more effective, targeted therapies for congenital diarrhea and enteropathies

Eunyoung Choi, PhD, and James Goldenring, MD, PhD. (photo by Erin O. Smith)
June 4, 2024

Grant funds research for therapies to prevent stomach cancer

The funds will help launch a clinical trial in the U.S. with one of the therapies and compare it with another therapy from an ongoing clinical trial in Japan.

July 7, 2023

Study reveals new clue to gastric cancer

Researchers at Vanderbilt University Medical Center have uncovered evidence of fibroblast cells’ direct involvement in the development of gastric cancer.

Izumi Kaji, PhD, and James Goldenring, MD, PhD, were among eight researchers from Vanderbilt University Medical Center honored last week by the American Physiological Society.
April 27, 2023

Researchers honored at American Physiology Summit

Three faculty members and five postdoctoral fellows at Vanderbilt University Medical Center received research honors last week from the American Physiological Society during its 2023 American Physiology Summit.

March 23, 2023

Goldenring’s gastrointestinal research contributions lauded

Vanderbilt’s James Goldenring, MD, PhD, has been honored by the American Gastroenterological Association for making significant contributions to understanding gastrointestinal disease.